Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-06-14
2005-06-14
Tate, Christopher (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S011400
Reexamination Certificate
active
06906032
ABSTRACT:
The present invention relates to cyclic peptides as inhibitors of urokinase binding to the urokinase receptor. Said cyclic peptides are suitable as pharmaceutical active substances for disorders mediated by urokinase and its receptor.
REFERENCES:
patent: WO 97 12905 (1997-04-01), None
patent: WO 98 21230 (1998-05-01), None
patent: WO 98 46632 (1998-10-01), None
Bürgle Markus
Kessler Horst
Potthoff Nils
Schmiedeberg Niko
Wilhelm Olaf
Harle Jennifer Ione
Rothwell Figg Ernst & Manbeck P.C.
Tate Christopher
Wilex AG
LandOfFree
Cyclic peptidomimetic urokinase receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic peptidomimetic urokinase receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic peptidomimetic urokinase receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3522850